Justin is the Vice President of Technical Operations at Caribou Biosciences which is a leading clinical-stage CRISPR genome-editing biopharmaceutical company advancing a pipeline of off-the-shelf CAR-T therapies for the treatment of patients with hematologic malignancies. He is responsible for developing, manufacturing, testing, and distributing the company’s critical raw materials and investigational products. Justin has over 20 years of development experience in the biotechnology sector with a focus on immuno-oncology including roles at Actym Therapeutics, Cerus Corporation, Anza Therapeutics, and Aduro Biotech. Justin earned his undergraduate degree in Biology from Vassar College, his Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, and did his post-doctoral fellowship at the University of California, San Francisco.